Literature DB >> 9092301

Human thyroglobulin reference material (CRM 457). 2nd Part: Physicochemical characterization and certification.

U Feldt-Rasmussen1, C Profilis, E Colinet, E Black, H Bornet, P Bourdoux, P Carayon, U B Ericsson, D A Koutras, L Lamas de Leon, P DeNayer, F Pacini, G Palumbo, A Santos, M Schlumberger, C Seidel, A J Van Herle, J J DeVijlder.   

Abstract

This report describes the characterization of a purified human thyroglobulin (Tg) reference material, and details the procedures used in its certification. The purified Tg is intended to be used as a primary reference material to establish calibration of working serum based reference material for immunoassay procedures. The programme involved the participation of 15 European laboratories and one laboratory from the United States. The physicochemical characterization showed by polyacrylamide gel electrophoresis and immunoblotting that the purified Tg had for the major part the expected molecular size of 660 kDa with traces of lower molecular forms. The amino acid composition was close to that demonstrated for the cDNA and the content of iodine was in keeping with a moderately to highly iodinated Tg. The mass concentration in reference material RM 457 is certified to be (0.324 +/- 0.018) g/L on the basis of protein determined by the Lowry method and supported by nitrogen determination, absorbance measurement, and amino acid analysis. This reference material is considered the first step towards decreasing the interlaboratory variability between Tg methods of measurement.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9092301

Source DB:  PubMed          Journal:  Ann Biol Clin (Paris)        ISSN: 0003-3898            Impact factor:   0.459


  9 in total

1.  Quantification of thyroglobulin, a low-abundance serum protein, by immunoaffinity peptide enrichment and tandem mass spectrometry.

Authors:  Andrew N Hoofnagle; Jessica O Becker; Mark H Wener; Jay W Heinecke
Journal:  Clin Chem       Date:  2008-09-18       Impact factor: 8.327

2.  The use of ultrasensitive thyroglobulin assays reduces but does not abolish the need for TSH stimulation in patients with differentiated thyroid carcinoma.

Authors:  M G Castagna; H P Tala Jury; C Cipri; V Belardini; C Fioravanti; L Pasqui; F Sestini; A Theodoropoulou; F Pacini
Journal:  J Endocrinol Invest       Date:  2011-03-07       Impact factor: 4.256

Review 3.  Iodine, thyroglobulin and thyroid gland.

Authors:  R Bílek; M Dvořáková; T Grimmichová; J Jiskra
Journal:  Physiol Res       Date:  2020-09-30       Impact factor: 1.881

Review 4.  Clinical review: improving the measurement of serum thyroglobulin with mass spectrometry.

Authors:  Andrew N Hoofnagle; Mara Y Roth
Journal:  J Clin Endocrinol Metab       Date:  2013-02-28       Impact factor: 5.958

Review 5.  How sensitive (second-generation) thyroglobulin measurement is changing paradigms for monitoring patients with differentiated thyroid cancer, in the absence or presence of thyroglobulin autoantibodies.

Authors:  Carole Spencer; Jonathan LoPresti; Shireen Fatemi
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2014-10       Impact factor: 3.243

6.  Serum thyroglobulin reference intervals in regions with adequate and more than adequate iodine intake.

Authors:  Zhaojun Wang; Hanyi Zhang; Xiaowen Zhang; Jie Sun; Cheng Han; Chenyan Li; Yongze Li; Xiaochun Teng; Chenling Fan; Aihua Liu; Zhongyan Shan; Chao Liu; Jianping Weng; Weiping Teng
Journal:  Medicine (Baltimore)       Date:  2016-11       Impact factor: 1.889

7.  Impact of Thyroglobulin and Thyroglobulin Antibody Assay Performance on the Differential Classification of DTC Patients.

Authors:  Lise Schoonen; Marjolein Neele; Hans van Toor; Caroline M J van Kinschot; Charlotte van Noord; W Edward Visser; Joost Groen; Lianne S M Boesten; Eef G W M Lentjes; Sjoerd A A van den Berg; Snjezana Kos
Journal:  J Endocr Soc       Date:  2021-11-10

8.  A sensitive Tg assay or rhTSH stimulated Tg: what's the best in the long-term follow-up of patients with differentiated thyroid carcinoma?

Authors:  Adrienne C M Persoon; Pieter L Jager; Wim J Sluiter; John T M Plukker; Bruce H R Wolffenbuttel; Thera P Links
Journal:  PLoS One       Date:  2007-08-29       Impact factor: 3.240

Review 9.  Thyroglobulin measurement using highly sensitive assays in patients with differentiated thyroid cancer: a clinical position paper.

Authors:  Luca Giovanella; Penelope M Clark; Luca Chiovato; Leonidas Duntas; Rossella Elisei; Ulla Feldt-Rasmussen; Laurence Leenhardt; Markus Luster; Camilla Schalin-Jäntti; Matthias Schott; Ettore Seregni; Herald Rimmele; Jan Smit; Frederik A Verburg
Journal:  Eur J Endocrinol       Date:  2014-04-17       Impact factor: 6.664

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.